Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endologix Inc (NASDAQ:ELGX)

5.22
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
4.08
Today|||52-Week Range
7.91
-8.74%
Year-to-Date
No recent news for Endologix Inc.

Today’s Trading

Previous close5.22
Today’s open5.24
Day’s range5.11 - 5.44
Volume528,738
Average volume (3 months)764,438
Market cap$434.0M
Dividend yield--
Data as of 4:00pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)-154.67%
Earnings growth (this year)+24.68%
Earnings growth (next 5 years)+95.60%
Revenue growth (last year)+25.59%
P/E ratioNM
Price/Sales2.40
Price/Book3.82

Competitors

 Today’s
change
Today’s
% change
CVRSCorindus Vascular Ro...0.000.00%
SRDXSurModics Inc0.000.00%
RMTIRockwell Medical Inc0.000.00%
TIGTigenix NV0.000.00%
Data as of 8:00pm ET, 11/22/2017

Financials

Next reporting dateFebruary 21, 2018
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$192.9M
Annual profit (last year)-$154.7M
Net profit margin-80.17%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
John D. McDermott
President
Robert D. Mitchell
Corporate headquarters
Irvine, California

Forecasts